Global Veterinary Biologics Market Research Report 2023
Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
According to QYResearch’s new survey, global Veterinary Biologics market is projected to reach US$ 17220 million in 2029, increasing from US$ 10810 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Biologics market research.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Veterinary Biologics market is projected to reach US$ 17220 million in 2029, increasing from US$ 10810 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Biologics market research.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco/Eli Lilly
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal
- Vaccines
- Monoclonal Antibodies
- Llivestock
- Equine
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 VETERINARY BIOLOGICS MARKET OVERVIEW
1.1 Product Overview and Scope of Veterinary Biologics
1.2 Veterinary Biologics Segment by Type
1.2.1 Global Veterinary Biologics Market Value Comparison by Type (2023-2029)
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Veterinary Biologics Segment by Application
1.3.1 Global Veterinary Biologics Market Value by Application: (2023-2029)
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biologics Revenue 2018-2029
1.4.2 Global Veterinary Biologics Sales 2018-2029
1.4.3 Global Veterinary Biologics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 VETERINARY BIOLOGICS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Veterinary Biologics Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Biologics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biologics, Product Type & Application
2.7 Veterinary Biologics Market Competitive Situation and Trends
2.7.1 Veterinary Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Biologics Players Market Share by Revenue
2.7.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 VETERINARY BIOLOGICS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Veterinary Biologics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Biologics Global Veterinary Biologics Sales by Region: 2018-2029
3.2.1 Global Veterinary Biologics Sales by Region: 2018-2023
3.2.2 Global Veterinary Biologics Sales by Region: 2024-2029
3.3 Global Veterinary Biologics Global Veterinary Biologics Revenue by Region: 2018-2029
3.3.1 Global Veterinary Biologics Revenue by Region: 2018-2023
3.3.2 Global Veterinary Biologics Revenue by Region: 2024-2029
3.4 North America Veterinary Biologics Market Facts & Figures by Country
3.4.1 North America Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Biologics Sales by Country (2018-2029)
3.4.3 North America Veterinary Biologics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biologics Market Facts & Figures by Country
3.5.1 Europe Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Biologics Sales by Country (2018-2029)
3.5.3 Europe Veterinary Biologics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Biologics Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Biologics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biologics Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Biologics Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Biologics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Biologics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Biologics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Veterinary Biologics Sales by Type (2018-2029)
4.1.1 Global Veterinary Biologics Sales by Type (2018-2023)
4.1.2 Global Veterinary Biologics Sales by Type (2024-2029)
4.1.3 Global Veterinary Biologics Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Biologics Revenue by Type (2018-2029)
4.2.1 Global Veterinary Biologics Revenue by Type (2018-2023)
4.2.2 Global Veterinary Biologics Revenue by Type (2024-2029)
4.2.3 Global Veterinary Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Biologics Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Veterinary Biologics Sales by Application (2018-2029)
5.1.1 Global Veterinary Biologics Sales by Application (2018-2023)
5.1.2 Global Veterinary Biologics Sales by Application (2024-2029)
5.1.3 Global Veterinary Biologics Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Biologics Revenue by Application (2018-2029)
5.2.1 Global Veterinary Biologics Revenue by Application (2018-2023)
5.2.2 Global Veterinary Biologics Revenue by Application (2024-2029)
5.2.3 Global Veterinary Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Biologics Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Veterinary Biologics Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zoetis Veterinary Biologics Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Veterinary Biologics Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAHIC Veterinary Biologics Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HVRI Veterinary Biologics Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ringpu Biology Veterinary Biologics Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Corporation Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yebio Veterinary Biologics Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 DHN Veterinary Biologics Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 WINSUN Veterinary Biologics Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco/Eli Lilly
6.11.1 Elanco/Eli Lilly Corporation Information
6.11.2 Elanco/Eli Lilly Veterinary Biologics Description and Business Overview
6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
6.11.5 Elanco/Eli Lilly Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Corporation Information
6.12.2 Virbac Veterinary Biologics Description and Business Overview
6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Virbac Veterinary Biologics Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Corporation Information
6.13.2 Jinyu Bio-Technology Veterinary Biologics Description and Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Veterinary Biologics Description and Business Overview
6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Veterinary Biologics Description and Business Overview
6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 CAVAC Veterinary Biologics Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken
6.16.1 Kyoto Biken Corporation Information
6.16.2 Kyoto Biken Veterinary Biologics Description and Business Overview
6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Kyoto Biken Veterinary Biologics Product Portfolio
6.16.5 Kyoto Biken Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Corporation Information
6.17.2 FATRO Veterinary Biologics Description and Business Overview
6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 FATRO Veterinary Biologics Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Corporation Information
6.18.2 Vaksindo Veterinary Biologics Description and Business Overview
6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Vaksindo Veterinary Biologics Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
6.19 Bio-Labs
6.19.1 Bio-Labs Corporation Information
6.19.2 Bio-Labs Veterinary Biologics Description and Business Overview
6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bio-Labs Veterinary Biologics Product Portfolio
6.19.5 Bio-Labs Recent Developments/Updates
6.20 Avimex Animal
6.20.1 Avimex Animal Corporation Information
6.20.2 Avimex Animal Veterinary Biologics Description and Business Overview
6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Avimex Animal Veterinary Biologics Product Portfolio
6.20.5 Avimex Animal Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Veterinary Biologics Industry Chain Analysis
7.2 Veterinary Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biologics Production Mode & Process
7.4 Veterinary Biologics Sales and Marketing
7.4.1 Veterinary Biologics Sales Channels
7.4.2 Veterinary Biologics Distributors
7.5 Veterinary Biologics Customers
8 VETERINARY BIOLOGICS MARKET DYNAMICS
8.1 Veterinary Biologics Industry Trends
8.2 Veterinary Biologics Market Drivers
8.3 Veterinary Biologics Market Challenges
8.4 Veterinary Biologics Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Veterinary Biologics
1.2 Veterinary Biologics Segment by Type
1.2.1 Global Veterinary Biologics Market Value Comparison by Type (2023-2029)
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Veterinary Biologics Segment by Application
1.3.1 Global Veterinary Biologics Market Value by Application: (2023-2029)
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biologics Revenue 2018-2029
1.4.2 Global Veterinary Biologics Sales 2018-2029
1.4.3 Global Veterinary Biologics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 VETERINARY BIOLOGICS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Veterinary Biologics Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Biologics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biologics, Product Type & Application
2.7 Veterinary Biologics Market Competitive Situation and Trends
2.7.1 Veterinary Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Biologics Players Market Share by Revenue
2.7.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 VETERINARY BIOLOGICS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Veterinary Biologics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Biologics Global Veterinary Biologics Sales by Region: 2018-2029
3.2.1 Global Veterinary Biologics Sales by Region: 2018-2023
3.2.2 Global Veterinary Biologics Sales by Region: 2024-2029
3.3 Global Veterinary Biologics Global Veterinary Biologics Revenue by Region: 2018-2029
3.3.1 Global Veterinary Biologics Revenue by Region: 2018-2023
3.3.2 Global Veterinary Biologics Revenue by Region: 2024-2029
3.4 North America Veterinary Biologics Market Facts & Figures by Country
3.4.1 North America Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Biologics Sales by Country (2018-2029)
3.4.3 North America Veterinary Biologics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biologics Market Facts & Figures by Country
3.5.1 Europe Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Biologics Sales by Country (2018-2029)
3.5.3 Europe Veterinary Biologics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Biologics Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Biologics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biologics Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Biologics Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Biologics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Biologics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Biologics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Veterinary Biologics Sales by Type (2018-2029)
4.1.1 Global Veterinary Biologics Sales by Type (2018-2023)
4.1.2 Global Veterinary Biologics Sales by Type (2024-2029)
4.1.3 Global Veterinary Biologics Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Biologics Revenue by Type (2018-2029)
4.2.1 Global Veterinary Biologics Revenue by Type (2018-2023)
4.2.2 Global Veterinary Biologics Revenue by Type (2024-2029)
4.2.3 Global Veterinary Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Biologics Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Veterinary Biologics Sales by Application (2018-2029)
5.1.1 Global Veterinary Biologics Sales by Application (2018-2023)
5.1.2 Global Veterinary Biologics Sales by Application (2024-2029)
5.1.3 Global Veterinary Biologics Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Biologics Revenue by Application (2018-2029)
5.2.1 Global Veterinary Biologics Revenue by Application (2018-2023)
5.2.2 Global Veterinary Biologics Revenue by Application (2024-2029)
5.2.3 Global Veterinary Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Biologics Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Veterinary Biologics Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zoetis Veterinary Biologics Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Veterinary Biologics Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAHIC Veterinary Biologics Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HVRI Veterinary Biologics Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ringpu Biology Veterinary Biologics Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Corporation Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yebio Veterinary Biologics Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 DHN Veterinary Biologics Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 WINSUN Veterinary Biologics Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco/Eli Lilly
6.11.1 Elanco/Eli Lilly Corporation Information
6.11.2 Elanco/Eli Lilly Veterinary Biologics Description and Business Overview
6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
6.11.5 Elanco/Eli Lilly Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Corporation Information
6.12.2 Virbac Veterinary Biologics Description and Business Overview
6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Virbac Veterinary Biologics Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Corporation Information
6.13.2 Jinyu Bio-Technology Veterinary Biologics Description and Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Veterinary Biologics Description and Business Overview
6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Veterinary Biologics Description and Business Overview
6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 CAVAC Veterinary Biologics Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken
6.16.1 Kyoto Biken Corporation Information
6.16.2 Kyoto Biken Veterinary Biologics Description and Business Overview
6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Kyoto Biken Veterinary Biologics Product Portfolio
6.16.5 Kyoto Biken Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Corporation Information
6.17.2 FATRO Veterinary Biologics Description and Business Overview
6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 FATRO Veterinary Biologics Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Corporation Information
6.18.2 Vaksindo Veterinary Biologics Description and Business Overview
6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Vaksindo Veterinary Biologics Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
6.19 Bio-Labs
6.19.1 Bio-Labs Corporation Information
6.19.2 Bio-Labs Veterinary Biologics Description and Business Overview
6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bio-Labs Veterinary Biologics Product Portfolio
6.19.5 Bio-Labs Recent Developments/Updates
6.20 Avimex Animal
6.20.1 Avimex Animal Corporation Information
6.20.2 Avimex Animal Veterinary Biologics Description and Business Overview
6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Avimex Animal Veterinary Biologics Product Portfolio
6.20.5 Avimex Animal Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Veterinary Biologics Industry Chain Analysis
7.2 Veterinary Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biologics Production Mode & Process
7.4 Veterinary Biologics Sales and Marketing
7.4.1 Veterinary Biologics Sales Channels
7.4.2 Veterinary Biologics Distributors
7.5 Veterinary Biologics Customers
8 VETERINARY BIOLOGICS MARKET DYNAMICS
8.1 Veterinary Biologics Industry Trends
8.2 Veterinary Biologics Market Drivers
8.3 Veterinary Biologics Market Challenges
8.4 Veterinary Biologics Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Veterinary Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Veterinary Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Veterinary Biologics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Biologics Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Veterinary Biologics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Veterinary Biologics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Veterinary Biologics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Veterinary Biologics Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Biologics Sales by Region (2018-2023) & (M Units)
Table 18. Global Veterinary Biologics Sales Market Share by Region (2018-2023)
Table 19. Global Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 20. Global Veterinary Biologics Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Veterinary Biologics Revenue Market Share by Region (2018-2023)
Table 23. Global Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Biologics Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 27. North America Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 28. North America Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 32. Europe Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 33. Europe Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Biologics Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Veterinary Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Biologics Sales (M Units) by Type (2018-2023)
Table 51. Global Veterinary Biologics Sales (M Units) by Type (2024-2029)
Table 52. Global Veterinary Biologics Sales Market Share by Type (2018-2023)
Table 53. Global Veterinary Biologics Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Biologics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Veterinary Biologics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Table 57. Global Veterinary Biologics Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Biologics Price (US$/Unit) by Type (2018-2023)
Table 59. Global Veterinary Biologics Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Biologics Sales (M Units) by Application (2018-2023)
Table 61. Global Veterinary Biologics Sales (M Units) by Application (2024-2029)
Table 62. Global Veterinary Biologics Sales Market Share by Application (2018-2023)
Table 63. Global Veterinary Biologics Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Biologics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Veterinary Biologics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Biologics Revenue Market Share by Application (2018-2023)
Table 67. Global Veterinary Biologics Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Biologics Price (US$/Unit) by Application (2018-2023)
Table 69. Global Veterinary Biologics Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Veterinary Biologics Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Zoetis Veterinary Biologics Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boehringer Ingelheim Veterinary Biologics Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Ceva Veterinary Biologics Product
Table 89. Ceva Recent Developments/Updates
Table 90. CAHIC Corporation Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CAHIC Veterinary Biologics Product
Table 94. CAHIC Recent Developments/Updates
Table 95. HVRI Corporation Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. HVRI Veterinary Biologics Product
Table 99. HVRI Recent Developments/Updates
Table 100. Ringpu Biology Corporation Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ringpu Biology Veterinary Biologics Product
Table 104. Ringpu Biology Recent Developments/Updates
Table 105. Yebio Corporation Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Yebio Veterinary Biologics Product
Table 109. Yebio Recent Developments/Updates
Table 110. DHN Corporation Information
Table 111. DHN Description and Business Overview
Table 112. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. DHN Veterinary Biologics Product
Table 114. DHN Recent Developments/Updates
Table 115. WINSUN Corporation Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. WINSUN Veterinary Biologics Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Elanco/Eli Lilly Corporation Information
Table 121. Elanco/Eli Lilly Description and Business Overview
Table 122. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Elanco/Eli Lilly Veterinary Biologics Product
Table 124. Elanco/Eli Lilly Recent Developments/Updates
Table 125. Virbac Corporation Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Virbac Veterinary Biologics Product
Table 129. Virbac Recent Developments/Updates
Table 130. Jinyu Bio-Technology Corporation Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Jinyu Bio-Technology Veterinary Biologics Product
Table 134. Jinyu Bio-Technology Recent Developments/Updates
Table 135. ChengDu Tecbond Corporation Information
Table 136. ChengDu Tecbond Description and Business Overview
Table 137. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. ChengDu Tecbond Veterinary Biologics Product
Table 139. ChengDu Tecbond Recent Developments/Updates
Table 140. CAVAC Corporation Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. CAVAC Veterinary Biologics Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Kyoto Biken Corporation Information
Table 146. Kyoto Biken Description and Business Overview
Table 147. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Kyoto Biken Veterinary Biologics Product
Table 149. Kyoto Biken Recent Developments/Updates
Table 150. FATRO Corporation Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. FATRO Veterinary Biologics Product
Table 154. FATRO Recent Developments/Updates
Table 155. Vaksindo Corporation Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Vaksindo Veterinary Biologics Product
Table 159. Vaksindo Recent Developments/Updates
Table 160. Bio-Labs Corporation Information
Table 161. Bio-Labs Description and Business Overview
Table 162. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Bio-Labs Veterinary Biologics Product
Table 164. Bio-Labs Recent Developments/Updates
Table 165. Avimex Animal Corporation Information
Table 166. Avimex Animal Description and Business Overview
Table 167. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Avimex Animal Veterinary Biologics Product
Table 169. Avimex Animal Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Veterinary Biologics Distributors List
Table 173. Veterinary Biologics Customers List
Table 174. Veterinary Biologics Market Trends
Table 175. Veterinary Biologics Market Drivers
Table 176. Veterinary Biologics Market Challenges
Table 177. Veterinary Biologics Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. Global Veterinary Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Veterinary Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Veterinary Biologics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Biologics Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Veterinary Biologics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Veterinary Biologics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Veterinary Biologics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Veterinary Biologics Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Biologics Sales by Region (2018-2023) & (M Units)
Table 18. Global Veterinary Biologics Sales Market Share by Region (2018-2023)
Table 19. Global Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 20. Global Veterinary Biologics Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Veterinary Biologics Revenue Market Share by Region (2018-2023)
Table 23. Global Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Biologics Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 27. North America Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 28. North America Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 32. Europe Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 33. Europe Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Biologics Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Veterinary Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Biologics Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Biologics Sales (M Units) by Type (2018-2023)
Table 51. Global Veterinary Biologics Sales (M Units) by Type (2024-2029)
Table 52. Global Veterinary Biologics Sales Market Share by Type (2018-2023)
Table 53. Global Veterinary Biologics Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Biologics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Veterinary Biologics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Table 57. Global Veterinary Biologics Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Biologics Price (US$/Unit) by Type (2018-2023)
Table 59. Global Veterinary Biologics Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Biologics Sales (M Units) by Application (2018-2023)
Table 61. Global Veterinary Biologics Sales (M Units) by Application (2024-2029)
Table 62. Global Veterinary Biologics Sales Market Share by Application (2018-2023)
Table 63. Global Veterinary Biologics Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Biologics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Veterinary Biologics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Biologics Revenue Market Share by Application (2018-2023)
Table 67. Global Veterinary Biologics Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Biologics Price (US$/Unit) by Application (2018-2023)
Table 69. Global Veterinary Biologics Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Veterinary Biologics Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Zoetis Veterinary Biologics Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boehringer Ingelheim Veterinary Biologics Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Ceva Veterinary Biologics Product
Table 89. Ceva Recent Developments/Updates
Table 90. CAHIC Corporation Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CAHIC Veterinary Biologics Product
Table 94. CAHIC Recent Developments/Updates
Table 95. HVRI Corporation Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. HVRI Veterinary Biologics Product
Table 99. HVRI Recent Developments/Updates
Table 100. Ringpu Biology Corporation Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ringpu Biology Veterinary Biologics Product
Table 104. Ringpu Biology Recent Developments/Updates
Table 105. Yebio Corporation Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Yebio Veterinary Biologics Product
Table 109. Yebio Recent Developments/Updates
Table 110. DHN Corporation Information
Table 111. DHN Description and Business Overview
Table 112. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. DHN Veterinary Biologics Product
Table 114. DHN Recent Developments/Updates
Table 115. WINSUN Corporation Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. WINSUN Veterinary Biologics Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Elanco/Eli Lilly Corporation Information
Table 121. Elanco/Eli Lilly Description and Business Overview
Table 122. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Elanco/Eli Lilly Veterinary Biologics Product
Table 124. Elanco/Eli Lilly Recent Developments/Updates
Table 125. Virbac Corporation Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Virbac Veterinary Biologics Product
Table 129. Virbac Recent Developments/Updates
Table 130. Jinyu Bio-Technology Corporation Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Jinyu Bio-Technology Veterinary Biologics Product
Table 134. Jinyu Bio-Technology Recent Developments/Updates
Table 135. ChengDu Tecbond Corporation Information
Table 136. ChengDu Tecbond Description and Business Overview
Table 137. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. ChengDu Tecbond Veterinary Biologics Product
Table 139. ChengDu Tecbond Recent Developments/Updates
Table 140. CAVAC Corporation Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. CAVAC Veterinary Biologics Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Kyoto Biken Corporation Information
Table 146. Kyoto Biken Description and Business Overview
Table 147. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Kyoto Biken Veterinary Biologics Product
Table 149. Kyoto Biken Recent Developments/Updates
Table 150. FATRO Corporation Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. FATRO Veterinary Biologics Product
Table 154. FATRO Recent Developments/Updates
Table 155. Vaksindo Corporation Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Vaksindo Veterinary Biologics Product
Table 159. Vaksindo Recent Developments/Updates
Table 160. Bio-Labs Corporation Information
Table 161. Bio-Labs Description and Business Overview
Table 162. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Bio-Labs Veterinary Biologics Product
Table 164. Bio-Labs Recent Developments/Updates
Table 165. Avimex Animal Corporation Information
Table 166. Avimex Animal Description and Business Overview
Table 167. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Avimex Animal Veterinary Biologics Product
Table 169. Avimex Animal Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Veterinary Biologics Distributors List
Table 173. Veterinary Biologics Customers List
Table 174. Veterinary Biologics Market Trends
Table 175. Veterinary Biologics Market Drivers
Table 176. Veterinary Biologics Market Challenges
Table 177. Veterinary Biologics Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Veterinary Biologics
Figure 2. Global Veterinary Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Veterinary Biologics Market Share by Type in 2022 & 2029
Figure 4. Vaccines Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Global Veterinary Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Veterinary Biologics Market Share by Application in 2022 & 2029
Figure 8. Llivestock
Figure 9. Equine
Figure 10. Other
Figure 11. Global Veterinary Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Veterinary Biologics Market Size (2018-2029) & (US$ Million)
Figure 13. Global Veterinary Biologics Sales (2018-2029) & (M Units)
Figure 14. Global Veterinary Biologics Average Price (US$/Unit) & (2018-2029)
Figure 15. Veterinary Biologics Report Years Considered
Figure 16. Veterinary Biologics Sales Share by Manufacturers in 2022
Figure 17. Global Veterinary Biologics Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Veterinary Biologics Players: Market Share by Revenue in 2022
Figure 19. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Veterinary Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 22. North America Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 23. United States Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 26. Europe Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 27. Germany Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Veterinary Biologics Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Veterinary Biologics Revenue Market Share by Region (2018-2029)
Figure 34. China Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 44. Latin America Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Veterinary Biologics by Type (2018-2029)
Figure 54. Global Revenue Market Share of Veterinary Biologics by Type (2018-2029)
Figure 55. Global Veterinary Biologics Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Veterinary Biologics by Application (2018-2029)
Figure 57. Global Revenue Market Share of Veterinary Biologics by Application (2018-2029)
Figure 58. Global Veterinary Biologics Price (US$/Unit) by Application (2018-2029)
Figure 59. Veterinary Biologics Value Chain
Figure 60. Veterinary Biologics Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Veterinary Biologics
Figure 2. Global Veterinary Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Veterinary Biologics Market Share by Type in 2022 & 2029
Figure 4. Vaccines Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Global Veterinary Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Veterinary Biologics Market Share by Application in 2022 & 2029
Figure 8. Llivestock
Figure 9. Equine
Figure 10. Other
Figure 11. Global Veterinary Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Veterinary Biologics Market Size (2018-2029) & (US$ Million)
Figure 13. Global Veterinary Biologics Sales (2018-2029) & (M Units)
Figure 14. Global Veterinary Biologics Average Price (US$/Unit) & (2018-2029)
Figure 15. Veterinary Biologics Report Years Considered
Figure 16. Veterinary Biologics Sales Share by Manufacturers in 2022
Figure 17. Global Veterinary Biologics Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Veterinary Biologics Players: Market Share by Revenue in 2022
Figure 19. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Veterinary Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 22. North America Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 23. United States Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 26. Europe Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 27. Germany Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Veterinary Biologics Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Veterinary Biologics Revenue Market Share by Region (2018-2029)
Figure 34. China Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 44. Latin America Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Veterinary Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Veterinary Biologics by Type (2018-2029)
Figure 54. Global Revenue Market Share of Veterinary Biologics by Type (2018-2029)
Figure 55. Global Veterinary Biologics Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Veterinary Biologics by Application (2018-2029)
Figure 57. Global Revenue Market Share of Veterinary Biologics by Application (2018-2029)
Figure 58. Global Veterinary Biologics Price (US$/Unit) by Application (2018-2029)
Figure 59. Veterinary Biologics Value Chain
Figure 60. Veterinary Biologics Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
